We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-26.82%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.65B
AUM Growth
+$109M
Cap. Flow
+$339M
Cap. Flow %
20.52%
Top 10 Hldgs %
53.93%
Holding
215
New
51
Increased
41
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 13.2%
2 Communication Services 8.08%
3 Consumer Discretionary 5.56%
4 Financials 3.95%
5 Materials 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEO
76
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$3M 0.18%
187,500
-57,480
-23% -$1.26M
SAMAU
77
DELISTED
Schultze Special Purpose Acquisition Corp. Unit
SAMAU
$2.98M 0.18%
+300,000
New +$2.99M
GGAL icon
78
Galicia Financial Group
GGAL
$8.06B
$2.9M 0.18%
105,000
SRRA
79
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.87M 0.17%
54,341
+9,341
+21% +$597K
MDC
80
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.81M 0.17%
116,640
SQBG
81
DELISTED
Sequential Brands Group, Inc.
SQBG
$2.69M 0.16%
83,905
AGRO icon
82
Adecoagro
AGRO
$1.43B
$2.44M 0.15%
350,000
TWNKW
83
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$2.34M 0.14%
2,520,000
-160,000
-6% -$160K
SLS icon
84
SELLAS Life Sciences
SLS
$1.96B
$2.34M 0.14%
38,000
+12,500
+49% +$968K
CHR icon
85
Cheer Holding
CHR
$3.6M
$2.17M 0.13%
150
TGTX icon
86
TG Therapeutics
TGTX
$7.96B
$2.05M 0.12%
500,000
TRAW icon
87
Traws Pharma
TRAW
$7.14M
$2.04M 0.12%
2,578
OTIC
88
DELISTED
Otonomy, Inc.
OTIC
$2.04M 0.12%
1,100,000
+300,000
+38% +$708K
AMCIU
89
DELISTED
AMCI Acquisition Corp Unit
AMCIU
$1.99M 0.12%
+200,000
New +$2M
BMTX
90
DELISTED
BM Technologies, Inc.
BMTX
$1.94M 0.12%
+200,000
New +$1.92M
ADMA icon
91
ADMA Biologics
ADMA
$1.96B
$1.92M 0.12%
805,000
DMK
92
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1.91M 0.12%
12,143
DHT icon
93
DHT Holdings
DHT
$3B
$1.82M 0.11%
465,000
+120,000
+35% +$556K
ZGNX
94
DELISTED
Zogenix, Inc.
ZGNX
$1.82M 0.11%
50,000
TCON
95
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.73M 0.1%
13,695
ARDX icon
96
Ardelyx
ARDX
$1.23B
$1.62M 0.1%
907,114
+257,114
+40% +$757K
ACHN
97
DELISTED
Achillion Pharmaceuticals
ACHN
$1.59M 0.1%
+1,000,000
New +$2.83M
BHF icon
98
Brighthouse Financial
BHF
$3.57B
$1.59M 0.1%
+52,100
New +$2.03M
CHAC.U
99
DELISTED
Chardan Healthcare Acquisition Corp.
CHAC.U
$1.51M 0.09%
+150,000
New +$1.5M
SLNO
100
DELISTED
Soleno Therapeutics
SLNO
$1.44M 0.09%
56,274

Similar funds

683 Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, 683 Capital Management held 215 positions worth $1.65B, up 7.1% from $1.54B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

683 Capital Management deployed $339M of net new capital in Q4 2018, opening 51 new positions and adding to 41 existing holdings. Its largest new stake was Capital One: 246,000 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Kroger, an estimated $7.83M trimmed.

  • 683 Capital Management's largest Q4 2018 buy was Capital One: 246,000 shares worth $18.6M.
  • 683 Capital Management added most to Scorpio Tankers in Q4 2018, an estimated $18M increase.
  • 683 Capital Management's biggest Q4 2018 reduction was Kroger, cutting an estimated $7.83M.
  • 683 Capital Management fully exited New York REIT, Inc. in Q4 2018, selling an estimated $15.5M.
  • 683 Capital Management's ten largest holdings make up 54% of its $1.65B portfolio in Q4 2018.
  • 683 Capital Management opened 51 new positions and closed 25 in Q4 2018.
  • 683 Capital Management's portfolio value rose 7.1% quarter-over-quarter to $1.65B.

Based on 683 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.